Skip to content

Press Releases

Date Title
18-May-2020 Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
04-May-2020 Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
30-Apr-2020 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
28-Apr-2020 Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
16-Apr-2020 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
14-Apr-2020 Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
27-Feb-2020 Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
12-Feb-2020 Illumina to Webcast Upcoming Investor Conference Presentations
06-Feb-2020 Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
29-Jan-2020 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
13-Jan-2020 Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
13-Jan-2020 Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
13-Jan-2020 Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
10-Jan-2020 Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
02-Jan-2020 Illumina and Pacific Biosciences Announce Termination of Merger Agreement